Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NvfiledCriticalJanssen Pharmaceutica Nv
Publication of UY30155A1publicationCriticalpatent/UY30155A1/en
La presente invención es un método para el tratamiento de una manía y/o trastorno bipolar que comprende administrar a un sujeto necesitado del mismo una cantidad efectiva para uso terapéutico de uno o más derivados novedosos de benzo-heteroaril sulfamida de fórmula (I) como los definidos en la presente.The present invention is a method for the treatment of a mania and / or bipolar disorder comprising administering to a subject in need thereof an effective amount for therapeutic use of one or more novel benzo-heteroaryl sulfamide derivatives of formula (I) such as defined herein.
UY30155A2006-02-152007-02-14
USE OF BENZO-HETEROARIL SULFAMIDA DERIVATIVES FOR THE TREATMENT OF MANIA AND BIPOLAR DISORDER
UY30155A1
(en)
Compounds derived from substituted pyrazolo-pyrimidines; pharmaceutical composition and combination that comprise them; and its use as inhibitors of pde9 for the treatment, relief and / or prevention of cognitive impairments related to perception, Alzheimer's, sleep disorders, bipolar disorder, diabetes mellitus.
Compounds derived from resolviin; pharmaceutical composition; use of the composition; pharmaceutical kit; pharmaceutical combination; use of the compounds in the treatment and / or prevention of an ophthalmic condition.
Nitrogen heterocycle derived compounds, gamma secretase modulators; pharmaceutical composition comprising them; and its use in the treatment of neurodegenerative diseases such as Alzheimer's, Down syndrome; pharmaceutical kit.